EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients

Azaz Ahmed, Sophia Köhler, Rosa Klotz iD, Nathalia Giese, Thilo Hackert, Christoph Springfeld, Dirk Jäger, Niels Halama

Cancers · 17.03.2023 · 15 (6) · 1815

DOI: 10.3390/cancers15061815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 17.03.2023. Verfasst von Azaz Ahmed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, 69120 Hei…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RR Pohl Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mounting evidence suggests that sex plays a critical role in various aspects of cancer such as immune responses. However, a male bias exists in human and non-human studies including immunotherapy trials. The role of sex on immune responses in pancreatic ductal adenocarcinoma (PDA) is unclear.

Methods

Here, tumor tissues (tumor and stroma separately) and corresponding blood samples from patients with PDA (n = 52) were systematically analyzed by immunohistochemistry and multiplex cytokine measurements and compared by sex.

Results

Females showed a stronger systemic immune response with higher levels of CXCL9, IL1B, IL6, IL10 and IL13. Additionally, more peripheral white blood cells were detected in females. In the microenvironment, males showed higher tumoral levels of CXCL12. No differences were detected in the stroma. Females showed a tendency towards an anti-tumoral immune cell profile. CXCL12 blockade indicated a differential microenvironmental effect by sex in an independent immunotherapy trial cohort of patients with PDA (one female, five males). The overall survival did not differ by sex in our cohort.

Conclusion

Systemic and local immune responses differ between sexes in PDA. Accordingly, sex-dependent differences need to be considered in human studies and for specific immunological interventions before clinical translation.

Schlagwörter

Stichwörter der Autor:innen

CXCL12pancreatic cancerpancreatic ductal adenocarcinomasex differencetumor immunology

Autor:innen und Institutionen

  • Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, 69120 Heidelberg, Germany.
  • Translational Immunotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, 69120 Heidelberg, Germany.
  • Applied Tumor Immunity Clinical Cooperation Unit, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

ORCID-Profile: Rosa Klotz

Förderung

  • RR Pohl Stiftung

Zitieren

APA

Ahmed, A., Köhler, S., Klotz, R., Giese, N., Hackert, T., Springfeld, C., Jäger, D., & Halama, N. (2023). Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Cancers, 15(6), 1815. https://doi.org/10.3390/cancers15061815

Vancouver

Ahmed A, Köhler S, Klotz R, Giese N, Hackert T, Springfeld C, et al. Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Cancers. 2023;15(6):1815. doi:10.3390/cancers15061815

BibTeX
@article{Ahmed2023,
  author = {Ahmed, Azaz and Köhler, Sophia and Klotz, Rosa and Giese, Nathalia and Hackert, Thilo and Springfeld, Christoph and Jäger, Dirk and Halama, Niels},
  title = {Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1815},
  doi = {10.3390/cancers15061815}
}
Kostenlos starten →